ABSTRACT
The location of these lesions and the odorous fluid that drained from them pointed to the diagnosis. The acne on the patient's back was another clue.
Subject(s)
Acne Vulgaris/complications , Axilla/abnormalities , Blister/etiology , Acne Vulgaris/physiopathology , Axilla/physiopathology , HumansABSTRACT
Although acne is the most common human inflammatory skin disease, its pathogenic mechanisms remain incompletely understood. Here we show that GATA6, which is expressed in the upper pilosebaceous unit of normal human skin, is down-regulated in acne. GATA6 controls keratinocyte proliferation and differentiation to prevent hyperkeratinisation of the infundibulum, which is the primary pathological event in acne. When overexpressed in immortalised human sebocytes, GATA6 triggers a junctional zone and sebaceous differentiation program whilst limiting lipid production and cell proliferation. It modulates the immunological repertoire of sebocytes, notably by upregulating PD-L1 and IL10. GATA6 expression contributes to the therapeutic effect of retinoic acid, the main treatment for acne. In a human sebaceous organoid model GATA6-mediated down-regulation of the infundibular differentiation program is mediated by induction of TGFß signalling. We conclude that GATA6 is involved in regulation of the upper pilosebaceous unit and may be an actionable target in the treatment of acne.
Subject(s)
Acne Vulgaris/metabolism , GATA6 Transcription Factor/metabolism , Sebaceous Glands/metabolism , Acne Vulgaris/genetics , Acne Vulgaris/pathology , Acne Vulgaris/physiopathology , B7-H1 Antigen/genetics , B7-H1 Antigen/metabolism , Cell Differentiation , GATA6 Transcription Factor/genetics , Homeostasis , Humans , Interleukin-10/genetics , Interleukin-10/metabolism , Keratinocytes/cytology , Keratinocytes/metabolism , Keratinocytes/pathology , Sebaceous Glands/cytology , Sebaceous Glands/pathology , Skin/cytology , Skin/metabolism , Skin/pathologyABSTRACT
Acne fulminans (AF) is a rare and severe form of inflammatory acne presenting clinically with an abrupt outburst of painful, hemorrhagic pustules and ulceration, that may or may not be associated with systemic symptoms, such as fever, polyarthritis, and laboratory abnormalities. It typically affects male teenagers with a pre-existing acne. Although the pathogenetic mechanism has not been established yet, a role of genetic, abnormal immunologic response, drugs intake, hormonal imbalance and viral infection, as causal factors, has been identified. AF may occur as a single disease or may be associated with other disorders. Traditionally, AF has been classified, on the basis of the presence of systemic involvement, in "acne fulminans" and acne fulminans "sine fulminans," when no systemic involvement is present. Recently, four clinical variants have been proposed: acne fulminans with systemic symptoms (AF-SS), acne fulminans without systemic symptoms (AF-WOSS), isotretinoin-induced acne fulminans with systemic symptoms (IIAF-SS), isotretinoin-induced acne fulminans without systemic symptoms (IIAF-WOSS). The diagnosis of AF is usually based on clinical history and physical examination. No specific laboratory abnormalities are generally found. In selected cases, biopsy and/or radiologic imaging are helpful for a correct diagnosis. The treatment significantly differs from severe acne according to severity of clinical presentation and possible systemic involvement. Currently, systemic corticosteroids (prednisolone) and retinoids (isotretinoin) represent the first choice of treatment. Dapsone, cyclosporine A, methotrexate, azathioprine, levamisole, and biological agents such as anakinra, infliximab, adalimumab may be considered as alternative therapies in selected cases. Adjunctive topical and physical therapies may also be considered.
Subject(s)
Acne Vulgaris , Acne Vulgaris/complications , Acne Vulgaris/diagnosis , Acne Vulgaris/physiopathology , Acne Vulgaris/therapy , Acquired Hyperostosis Syndrome/complications , Acquired Hyperostosis Syndrome/diagnosis , Adolescent , Adrenal Cortex Hormones/therapeutic use , Adult , Androgens/adverse effects , Anti-Inflammatory Agents/therapeutic use , Arthralgia/complications , Combined Modality Therapy , Debridement , Dermatologic Agents/therapeutic use , Diagnosis, Differential , Disease Progression , Female , Humans , Immunosuppressive Agents/therapeutic use , Inflammation , Isotretinoin/adverse effects , Isotretinoin/therapeutic use , Lasers, Dye , Low-Level Light Therapy , Male , Photochemotherapy , Propionibacteriaceae/immunology , Retinoids/therapeutic use , Symptom Assessment , Young AdultABSTRACT
OBJECTIVE: Isotretinoin is used in acne vulgaris treatment for more than 20 years. Isotretinoin has serious side effects on many organs, but there are no comprehensive studies investigating its possible toxic effects on reproductive organs. Thus, we aimed to investigate the possible toxic effects of isotretinoin administration on oocyte maturation in female rat gonads in this study. METHODS: Thirty-two adolescent female rats (Wistar Albino, 220 ± 35 g) were randomly divided into 4 groups with 8 subjects in each group: group 1, group 2, group 3, and group 4. Different doses of isotretinoin which was dissolved in sesame oil were given to rats by gavage: 7.5 mg/kg/day in group 3 and 15 mg/kg/day in group 4. The rats in group 2 received sesame oil by gavage. To create gavage stress, only gavage was administered to the rats in group 1. The gavages for each group continued once a day and at a certain time for 30 days. To determine the effect of isotretinoin on oocyte maturation, the periodic acid-Schiff reaction was performed for histochemical and histomorphometric evaluation of the zona pellucida, and staining of growth differentiation factor-9 (GDF-9) and bone morphogenetic protein-15 (BMP-15) was performed for immunohistochemical analysis. RESULTS: When the thickness of the zona pellucida was evaluated, a statistically significant difference was found between group 1 and experimental groups (group 3 and group 4). In the experimental groups, it was determined that the thickness of the zona pellucida was decreased depending on the increase in dose. GDF-9 and BMP-15 expressions in oocytes of primordial and primary follicles decreased significantly in the experimental groups compared to group 1 and group 2. However, the expression of GDF-9 and BMP-15 in oocytes of secondary follicles was not significantly different between group 1 and group 2 and the experimental groups. CONCLUSIONS: In our study, we showed toxic effect of isotretinoin on oocyte maturation in female rats.
Subject(s)
Acne Vulgaris/drug therapy , Dermatologic Agents/adverse effects , Isotretinoin/adverse effects , Oocytes/drug effects , Oogenesis/drug effects , Acne Vulgaris/physiopathology , Animals , Bone Morphogenetic Protein 15/metabolism , Female , Growth Differentiation Factor 9/metabolism , Oocytes/growth & development , Ovarian Follicle/metabolism , Rats , Rats, Wistar , Zona Pellucida/drug effectsABSTRACT
Pyogenic arthritis, pyoderma gangrenosum (PG) and acne (PAPA) syndrome is an autosomal dominant autoinflammatory syndrome due to mutations in proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1) gene and presenting with cutaneous and articular manifestations. Other autoinflammatory syndromes caused by mutations in PSTPIP1 gene or characterized by clinical findings overlapping with those found in PAPA syndrome have been recently included in the group of PAPA spectrum disorders. These disorders are PASH (PG, acne and hidradenitis suppurativa [HS]), PAPASH (PASH associated with pyogenic sterile arthritis), PsAPASH (PASH combined with psoriatic arthritis [PsA], PASS (PG, acne, ankylosing spondylitis, with or without HS), PAC (PG, acne and ulcerative colitis [UC]) and PAMI syndrome (PSTPIP1-associated myeloid-related-proteinemia inflammatory syndrome). Except for PAPA and PAMI, no specific pathogenetic mutations have been identified in these syndromes. Dermatologists should be aware that PG, acne and HS may represent cutaneous signs hiding the presence of these rare entities. Systemic corticosteroids, a number of immunosuppressants and biologics, such as interleukin (IL)-1 antagonists and tumour necrosis factor (TNF) α inhibitors, are nowadays therapy for these diseases. A pathogenesis-driven treatment is the near future in the management of these conditions.
Subject(s)
Acne Vulgaris , Arthritis, Infectious , Pyoderma Gangrenosum , Acne Vulgaris/diagnosis , Acne Vulgaris/drug therapy , Acne Vulgaris/physiopathology , Arthritis, Infectious/diagnosis , Arthritis, Infectious/drug therapy , Arthritis, Infectious/physiopathology , Humans , Pyoderma Gangrenosum/diagnosis , Pyoderma Gangrenosum/drug therapy , Pyoderma Gangrenosum/physiopathologySubject(s)
Acne Vulgaris/diagnosis , Acne Vulgaris/therapy , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/therapy , Pediatrics/methods , Warts/diagnosis , Warts/therapy , Acne Vulgaris/physiopathology , Adolescent , Child , Child, Preschool , Dermatitis, Atopic/physiopathology , Dermatologists , Female , Humans , Infant , Male , Pediatricians , Physicians, Family , Warts/physiopathologyABSTRACT
BACKGROUND: Due to the ever-increasing demands for the personalized care, people seek for the tailored management according to the accurate identification of their skin type. The Baumann Skin Type Indicator, which was proposed by Leslie Baumann, is composed of four parameters: oily or dry, resistant or sensitive, pigmented or nonpigmented, and wrinkled or tight. Among these, oily sensitive skin experiences significant discomfort and resists ordinary treatment. AIMS: In this article, we will review the clinical manifestations, underlying pathogenesis and recommendations on treatment options that may be utilized to help patients with oily sensitive skin. PATIENTS/METHODS: Literature search was conducted using PubMed. The literature concerning Baumann Skin Type Indicator and oily sensitive skin type were considered. RESULTS: Oily sensitive (OS)-type skin is a complex of oily and sensitive skin that causes significant discomfort and undergoes stubborn resistance to treatments. Sebum dysfunction and hypersensitivity may play a key role in the development of sensitive skin. Considering the pathogenesis of OS-type skin, treatment should focus on both seborrhea and hypersensitivity. CONCLUSION: Clinicians can effectively treat the oily sensitive skin by understanding underlying pathogenesis of it. Further investigations are necessary to reach a consensus on the basic pathophysiology and optimal management guidelines for oily sensitive skin.
Subject(s)
Acne Vulgaris/therapy , Cosmetic Techniques/standards , Dermatitis, Contact/therapy , Dermatitis, Seborrheic/therapy , Rosacea/therapy , Acne Vulgaris/physiopathology , Administration, Cutaneous , Administration, Oral , Anti-Bacterial Agents/administration & dosage , Botulinum Toxins/administration & dosage , Botulinum Toxins/adverse effects , Cosmetic Techniques/adverse effects , Dermatitis, Contact/physiopathology , Dermatitis, Seborrheic/physiopathology , Humans , Injections, Intradermal , Isotretinoin/administration & dosage , Isotretinoin/adverse effects , Keratolytic Agents/administration & dosage , Keratolytic Agents/adverse effects , Practice Guidelines as Topic , Rosacea/physiopathology , Sebum/metabolism , Skin/metabolism , Skin/physiopathology , Treatment OutcomeABSTRACT
Acne is a disease unique to humans and is associated with sebaceous glands that are found at high density on the scalp, forehead and face. Despite being a near universal problem in adolescence, the reason why such troublesome sebaceous glands exist at all is not well understood. Some interesting theories have been postulated including roles for skin maintenance, immunological function and perhaps even pheromones, but pre-pubertal skin which has sebaceous glands that are largely inactive, is healthy. Dystocia, obstructed labour, is unique to humans and no other animal has as much trouble giving birth. This is thought to reflect the relatively large human foetal head and proportionally small maternal pelvis. Noting the high density of sebaceous glands on the face, chest and back; these are exactly the same structures that pose the greatest obstruction during childbirth. Sebaceous glands develop after the fourth month of gestation and are large and well-developed at birth. Sebum production is also relatively high at birth. Having extra lubrication at these sites would help make the baby more slippery for birth conferring a selective advantage to successful delivery, as does the presence of the vernix caseosa, a white creamy substance, unique to humans that coats new-born infants. It is proposed that the sebaceous glands that cause acne are present on the face and forehead as they confer a selective advantage by 'lubricating' the widest parts of the new born baby to ease the passage of childbirth. Later in life, sebaceous glands may be inappropriately and pathologically primed, driven by a combination of hormones, diet and lifestyle to create acne.
Subject(s)
Acne Vulgaris/etiology , Models, Biological , Sebaceous Glands/physiology , Acne Vulgaris/microbiology , Acne Vulgaris/physiopathology , Adolescent , Androgens/physiology , Biofilms , Diet , Dystocia , Female , Hair Follicle/pathology , Head/embryology , Humans , Infant, Newborn , Inflammation , Organ Size , Parturition , Pregnancy , Propionibacterium acnes/physiology , Scalp/pathology , Sebaceous Glands/physiopathology , Sebum/microbiology , Sebum/physiology , Selection, Genetic , Species Specificity , Vernix Caseosa/physiologyABSTRACT
To define the spectrum and phenotypic characteristics of systemic autoinflammatory diseases (SAIDs) other than familial Mediterranean fever (FMF) in Arab children and to delineate diagnostic evaluation. Data retrospectively collected on patients with clinical and/or genetically proven SAIDs other than FMF at 10 tertiary Arab pediatric rheumatology clinics from 1990 to 2018. The collected data comprised the clinical findings and diagnostic evaluation including genetic testing, the provided treatment and the accrual damage related to SAIDs. A total of 144 patients (93 female) with a median age at onset of 2.5 (range 0.1-12) years were enrolled. The initial diagnosis was inaccurate in 49.3%. Consanguinity rate among parents was 74.6%. The median time-to-diagnosis for all SAIDs was 2.5 (range 0.1-10) years. There were 104 patients (72.2%) with a confirmed diagnosis and 40 patients with suspected SAIDs. Seventy-two had monogenic and 66 patients with multifactorial SAIDs while six patients had undifferentiated SAIDs. The most frequent monogenic SAIDs were LACC1 mediated monogenic disorders (n = 23) followed by CAPS (12), TRAPS (12), HIDS (12), and Majeed's syndrome (6). The most frequent multifactorial SAIDs was CRMO (34), followed by PFAPA (18), and early onset sarcoidosis (EOS) (14). Genetic analysis was performed in 69 patients; 50 patients had genetically confirmed disease. Corticosteroid used for 93 patients while biologic agents for 96 patients. Overall, growth failure was the most frequent accrual damage (36%), followed by cognitive impairment (13%). There were three deaths because of infection. This study shows a heterogenous spectrum of SAIDs with a high number of genetically confirmed monogenic diseases; notably, LACC1 associated diseases. Hopefully, this work will be the first step for a prospective registry for SAIDs in Arab countries.
Subject(s)
Hereditary Autoinflammatory Diseases/diagnosis , Hereditary Autoinflammatory Diseases/epidemiology , Acne Vulgaris/diagnosis , Acne Vulgaris/drug therapy , Acne Vulgaris/epidemiology , Acne Vulgaris/physiopathology , Adolescent , Anemia, Dyserythropoietic, Congenital/diagnosis , Anemia, Dyserythropoietic, Congenital/drug therapy , Anemia, Dyserythropoietic, Congenital/epidemiology , Anemia, Dyserythropoietic, Congenital/physiopathology , Antirheumatic Agents/therapeutic use , Arabs , Arthritis/diagnosis , Arthritis/drug therapy , Arthritis/epidemiology , Arthritis/physiopathology , Arthritis, Infectious/diagnosis , Arthritis, Infectious/drug therapy , Arthritis, Infectious/epidemiology , Arthritis, Infectious/physiopathology , Arthritis, Juvenile/drug therapy , Arthritis, Juvenile/epidemiology , Arthritis, Juvenile/genetics , Arthritis, Juvenile/physiopathology , Bahrain/epidemiology , Child , Child, Preschool , Consanguinity , Crohn Disease/drug therapy , Crohn Disease/epidemiology , Crohn Disease/genetics , Crohn Disease/physiopathology , Cross-Sectional Studies , Cryopyrin-Associated Periodic Syndromes/diagnosis , Cryopyrin-Associated Periodic Syndromes/drug therapy , Cryopyrin-Associated Periodic Syndromes/epidemiology , Cryopyrin-Associated Periodic Syndromes/physiopathology , Diagnostic Errors , Female , Fever/diagnosis , Fever/drug therapy , Fever/epidemiology , Fever/physiopathology , Hereditary Autoinflammatory Diseases/drug therapy , Hereditary Autoinflammatory Diseases/physiopathology , Humans , Immunologic Deficiency Syndromes/diagnosis , Immunologic Deficiency Syndromes/drug therapy , Immunologic Deficiency Syndromes/epidemiology , Immunologic Deficiency Syndromes/physiopathology , InfantABSTRACT
Expression of caveolin-1 (Cav-1) is an important pathophysiological factor in acne. Cav-1 strongly interacts with such well-recognized etiopathogenic factors such as hyperseborrhea, follicular hyperkeratinization and pathogenicity of Cutibacterium acnes. Cav-1 is a strong negative regulator of transforming growth factor beta (TGF-ß) expression. It acts as a critical determinant of autophagy, which is significantly induced in acne lesions through C. acnes and by absorption of fatty acids. Cav-1 also demonstrates different correlations with the development of innate immunity. We propose that normalization of Cav-1 expression can serve as a target in anti-acne therapy.
Subject(s)
Acne Vulgaris/metabolism , Caveolin 1/physiology , Epithelial Cells/physiology , Acne Vulgaris/drug therapy , Acne Vulgaris/physiopathology , Adipocytes/metabolism , Autophagy , Caveolin 1/metabolism , Fatty Acids/metabolism , Host-Pathogen Interactions , Humans , Immunity, Innate , Sebaceous Glands/pathology , Sebaceous Glands/physiopathologyABSTRACT
Acne vulgaris is the most common dermatological disorder globally.1,2 Psychological and emotional distress due to acne, including poor self-esteem, social anxiety, depression, and suicidal ideation have been reported in various studies.3,4, Acne is a complex multifactorial disease with its pathophysiology incompletely elucidated.
Subject(s)
Acne Vulgaris/physiopathology , Skin Care/methods , Skin Physiological Phenomena , Acne Vulgaris/psychology , Acne Vulgaris/therapy , Humans , Hydrogen-Ion Concentration , Skin/metabolism , Skin/physiopathologySubject(s)
Acne Vulgaris , Acne Vulgaris/diagnosis , Acne Vulgaris/drug therapy , Acne Vulgaris/physiopathology , Administration, Topical , Adolescent , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Child , Child, Preschool , Contraceptives, Oral, Hormonal/therapeutic use , Dermatologic Agents/therapeutic use , Diet , Humans , Hygiene , Infant , Infant, Newborn , Laser Therapy , Retinoids/therapeutic useABSTRACT
INTRODUCTION: Acne is a common skin disease with important psychosocial impact. Often inadequate compliance affects the efficacy of the therapy. Because of emerging use of mobile and electronic health technology, the recent literature evaluated the helpfulness of the tools in medication adherence. The first goal of our study was to evaluate the adherence to therapy with topical adapalene 0.3%/benzoyl peroxide (A-BPO) 2.5% in different groups of patients who received explicative information supported by different strategies. The second goal was to evaluate the patient's quality of life and skin parameters. MATERIALS AND METHODS: We enrolled 126 subjects with mild to severe acne vulgaris. They were randomized into 3 groups of 42 patients each and applied daily topical A-BPO (0.3%, 2.5%) for 12 weeks. The first group (G1) was trained on the gel application by an explicative leaflet. The second group (G2) received the same instructions as group 1 and a daily SMS to remind them of the application of the product. The third group (G3) only received standard instructions. Evaluations were performed at the beginning of treatment (T0) and after 12 weeks (T1): assessment of acne severity using the Investigator's Global Assessment (IGA) Scale for Acne Severity, quality of life by the Cardiff Acne Disability Index (CADI) and the Patient-Doctor Relationship Depth-of-Relationship Scale (PDRDS), skin pH, grade of hydration and adherence to treatment with a 7-day recall calendar were also measured. RESULTS: After 12 weeks of therapy, we observed a reduction in IGA in all groups confirming the clinical efficacy of the product. In the multiple comparison analysis of IGA score reduction, a significant difference was found in G2 versus G1 and G2 versus G3, while the G1 versus G3 comparison was not statistically significant. However, the leaflet group (G1) showed better results compared to the no-leaflet group (G3). Supporting these data, we observed that adherence days correlated positively with the improvement of the single parameters. Moreover, we observed that SMS and leaflet groups had a greater improvement in quality of life evaluated by CADI and PDRDS scores. CONCLUSIONS: According to our data, this experimental setup based on text message service and leaflet service is inexpensive and easy to use. Physicians could consider using these items in their practice to enhance patient adherence and satisfaction as well as treatment outcome.
Subject(s)
Acne Vulgaris/drug therapy , Adapalene, Benzoyl Peroxide Drug Combination/administration & dosage , Dermatologic Agents/administration & dosage , Medication Adherence , Pamphlets , Text Messaging , Acne Vulgaris/physiopathology , Adolescent , Female , Gels , Humans , Hydrogen-Ion Concentration , Male , Physician-Patient Relations , Quality of Life , Severity of Illness Index , Skin/physiopathology , Water/metabolism , Young AdultABSTRACT
OBJECTIVES: Using anti-androgenic contraception is one of the methods of birth control. It also has a significant, non-contraceptiveimpact on women's body. These drugs can be used in various endocrinological disorders, because of their abilityto reduce the level of male hormones.The aim of our study is to establish a correlation between taking different types of anti-androgenic drugs and intensity ofhirsutism, acne, menstrual pain intensity and sexuality. MATERIAL AND METHODS: 570 women in childbearing age that had been using oral contraception for at least three monthstook part in our research. We examined women and asked them about quality of life, health, direct causes and effects ofthat treatment, intensity of acne and menstrual pain before and after. Our research group has been divided according tothe type of gestagen contained in the contraceptive pill: dienogest, cyproterone, chlormadynone and drospirenone. Additionally,the control group consisted of women taking oral contraceptives without antiandrogenic component. RESULTS: The mean age of the studied group was 23 years ± 3.23. 225 of 570 women complained of hirsutism.The mean score for acne intensity before the use of contraception was 2.7 ± 1.34. The mean score for acne intensity after3 months of using contraception was 1.85 ± 1.02 (p < 0.001). 192 women reported excess hairiness in one or more areabefore treatment. Mean value based on Ferriman-Gallway scale before the treatment was 6.23 ± 6.21 and 5.39 ± 5.6 afterthe treatment (p < 0.001). CONCLUSIONS: All groups of drugs effectively reduced pain and acne severity. Cyproterone and drospirenone turned outas the most effective drugs in treating hirsutism. Surprisingly, according to our research, dienogest does not have anyimpact on body hairiness.
Subject(s)
Acne Vulgaris , Androgen Antagonists , Contraceptives, Oral , Dysmenorrhea , Hirsutism , Acne Vulgaris/drug therapy , Acne Vulgaris/physiopathology , Adult , Androgen Antagonists/pharmacology , Androgen Antagonists/therapeutic use , Androstenes/pharmacology , Androstenes/therapeutic use , Contraceptives, Oral/pharmacology , Contraceptives, Oral/therapeutic use , Cyproterone/pharmacology , Cyproterone/therapeutic use , Dysmenorrhea/drug therapy , Dysmenorrhea/physiopathology , Female , Hirsutism/drug therapy , Hirsutism/physiopathology , Humans , Prospective Studies , Quality of Life , Sexuality/drug effects , Young AdultABSTRACT
Acne vulgaris is a common disease which affects about 85% of the population. Various topical drugs are available, but the retinoid derivatives are mostly taken into consideration. They are used as a first-line treatment drugs. However, they also have few side effects. Whereas, adapalene which is a third generation topical retinoid has fewer side effects compared to other derivatives. In this, we hypothesize that the combination therapy of adapalene and flavonoid could improve the efficacy and thereby it can also decrease the treatment time. Since, flavonoids possess multiple activities we assume that it can improve the action of the drug by showing a synergistic activity. Moreover, when we incorporate these two drugs in nanoemulgel, it can easily penetrate into the skin and produce its therapeutic action. Hence, we assume that if this hypothesis proves to be correct then this method will be an effective one in treating acne (pustule).
Subject(s)
Acne Vulgaris/drug therapy , Adapalene/therapeutic use , Polyphenols/therapeutic use , Acne Vulgaris/physiopathology , Adapalene/administration & dosage , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Dermatologic Agents/classification , Dermatologic Agents/therapeutic use , Disease Models, Animal , Drug Combinations , Drug Evaluation, Preclinical , Drug Synergism , Emulsions , Female , Humans , Male , Mice , Nanogels , Polyphenols/administration & dosage , Rabbits , Rats , Receptors, Retinoic Acid/agonistsABSTRACT
Drug development continues to focus on the challenge of treating acne effectively and safely. Inflammation is a backdrop to the commonly cited elements of the pathophysiology of acne: Propionibacterium acnes proliferation, increased sebum production with an increase in circulating androgens, and faulty keratinization. As such, there is increased emphasis on targeting inflammation and its effects. Vehicle innovations are optimizing existing active drugs and creating opportunities to deliver new compounds to the skin. Recently approved sarecycline is the first new chemical entity approved for acne in several years. It might be followed in coming years by other new actives, including clascoterone and cannabidiol (CBD).
Subject(s)
Acne Vulgaris/drug therapy , Dermatologic Agents/administration & dosage , Inflammation/drug therapy , Acne Vulgaris/physiopathology , Drug Delivery Systems , Drug Development , Humans , Inflammation/physiopathology , Propionibacterium acnes/isolation & purification , Sebum/metabolism , Tetracyclines/administration & dosageABSTRACT
METHOD: A qualitative descriptive study collected data via telephone interviews with 20 purposively sampled GPs working in New South Wales. A thematic analysis guided by the study objectives was undertaken. RESULTS: The participating GPs had divergent management approaches to acne treatment, infrequently provided acne patients with written resources, and would value additional dermatological support. Furthermore, the GPs recognised psychosocial ramifications and patient distress as drivers for treatment and expedited referral to dermatologists. DISCUSSION: Avenues for improved patient outcomes include explicit attention to psychological morbidity beyond treatment of the acne itself and improved use of patient educational materials, along with consistent collaboration between GPs and dermatologists.
Subject(s)
Acne Vulgaris/therapy , General Practitioners/psychology , Practice Patterns, Physicians'/standards , Acne Vulgaris/physiopathology , Adult , Attitude of Health Personnel , Female , General Practice/methods , Humans , Interviews as Topic/methods , Male , Middle Aged , New South Wales , Practice Patterns, Physicians'/trends , Qualitative ResearchABSTRACT
Dermatologic diseases have a similar influence on quality of life (QoL) and disability as other chronic medical conditions. Although QoL has been studied in relation to acne, eczema, and psoriasis, there is little information on how patients conceptualize their diseases - the illness experience. More information about illness perception (IP) and the impact of these perceptions on QoL, will help clinicians identify and address patients' conceptions, with the potential to positively impact patients' wellbeing. We sought to examine the effect of IP on QoL and make comparisons across acne, psoriasis, and eczema among a diverse population. A cross-sectional survey-based study was completed anonymously by patients presenting to an urban university hospital-based dermatology clinic. In our final model, we showed that IP was independently associated with overall QoL. A secondary finding showed that overall QoL was significantly worse for nonwhite patients compared to white patients. Our results are based on patient survey data, without correlation with objective clinical information. Taken together, our data demonstrate a direct relationship between IP and QoL in three common dermatologic conditions in a clinic-based setting and suggest that this relationship may be influenced by group differences, such as race/ethnicity.
Subject(s)
Acne Vulgaris/psychology , Attitude to Health , Eczema/psychology , Ethnicity , Psoriasis/psychology , Quality of Life , Acne Vulgaris/physiopathology , Adolescent , Adult , Black or African American , Aged , Aged, 80 and over , Asian , Eczema/physiopathology , Emotions , Female , Hispanic or Latino , Humans , Male , Middle Aged , Psoriasis/physiopathology , Severity of Illness Index , Surveys and Questionnaires , White People , Young AdultABSTRACT
BACKGROUND: Cutibacterium acnes has been identified as one of the main triggers of acne. However, increasing knowledge of the human skin microbiome raises questions about the role of other skin commensals, such as Staphylococcus epidermidis, in the physiopathology of this skin disease. SUMMARY: This review provides an overview of current knowledge of the potential role of S. epidermidis in the physiopathology of acne. Recent research indicates that acne might be the result of an unbalanced equilibrium between C. acnes and S. epidermidis,according to dedicated interactions. Current treatments act on C. acnesonly. Other treatment options may be considered, such as probiotics derived from S. epidermidis to restore the naturally balanced microbiota or through targeting the regulation of the host's AMP mediators. Key Messages: Research seems to confirm the beneficial role of S. epidermidis in acne by limiting C. acnes over-colonisation and inflammation.